NT5DC3 and neoplasm: NT5DC3 has been shown to suppress cell proliferation and induce cell cycle arrest [63], as well as being an inhibitor of tumour suppressors such as p53 [64], making it an interesting biomarker in the study of ICA, since targeting NT5DC3 could reduce adenosine levels, restore immune function, and enhance the effectiveness of immunotherapies.